Current Ratio of Checkpoint Therapeutics, Inc. from 30 Jun 2017 to 31 Mar 2025

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Checkpoint Therapeutics, Inc. quarterly Current Ratio in % history and change rate from 30 Jun 2017 to 31 Mar 2025.
  • Checkpoint Therapeutics, Inc. Current Ratio for the quarter ending 31 Mar 2025 was 68%, a 128% increase year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Change (%)

Checkpoint Therapeutics, Inc. Quarterly Current Ratio (%)

Period Value YoY Chg Change % Date
Q1 2025 68% +38% +128% 31 Mar 2025
Q4 2024 37% +15% +69% 31 Dec 2024
Q3 2024 35% +9.2% +35% 30 Sep 2024
Q2 2024 30% -12% -29% 30 Jun 2024
Q1 2024 30% -37% -56% 31 Mar 2024
Q4 2023 22% -85% -79% 31 Dec 2023
Q3 2023 26% -132% -83% 30 Sep 2023
Q2 2023 43% -180% -81% 30 Jun 2023
Q1 2023 67% -251% -79% 31 Mar 2023
Q4 2022 107% -334% -76% 31 Dec 2022
Q3 2022 158% -471% -75% 30 Sep 2022
Q2 2022 222% -484% -69% 30 Jun 2022
Q1 2022 318% -274% -46% 31 Mar 2022
Q4 2021 440% -23% -4.9% 31 Dec 2021
Q3 2021 629% +234% +59% 30 Sep 2021
Q2 2021 706% +422% +149% 30 Jun 2021
Q1 2021 592% +335% +130% 31 Mar 2021
Q4 2020 463% +240% +108% 31 Dec 2020
Q3 2020 395% +208% +111% 30 Sep 2020
Q2 2020 284% +58% +25% 30 Jun 2020
Q1 2020 257% -15% -5.6% 31 Mar 2020
Q4 2019 223% -113% -34% 31 Dec 2019
Q3 2019 187% -214% -53% 30 Sep 2019
Q2 2019 226% -200% -47% 30 Jun 2019
Q1 2019 272% -199% -42% 31 Mar 2019
Q4 2018 336% -194% -37% 31 Dec 2018
Q3 2018 401% -290% -42% 30 Sep 2018
Q2 2018 426% -408% -49% 30 Jun 2018
Q1 2018 471% 31 Mar 2018
Q4 2017 529% 31 Dec 2017
Q3 2017 690% 30 Sep 2017
Q2 2017 834% 30 Jun 2017
* An asterisk sign (*) next to the value indicates that the value is likely invalid.